AI assistant
Comvita Limited — Director's Dealing 2020
Mar 17, 2020
66182_rns_2020-03-18_1f25c15c-b177-4a1f-bc33-499233ba5536.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [88 x 24] intentionally omitted <==
==> picture [179 x 81] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:
Comvita Limited 18-Mar-20 16-Jun-17
Director or senior manager giving disclosure
Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products: Nature of the affected relevant interest(s): For that relevant interest- Number held in class before acquisition or disposal: Number held in class after acquisition or disposal: Current registered holder(s): Registered holder(s) once transfers are registered:
Lucas Nicholas Elias Bunt Comvita Limited n/a Company Director
Ordinary Shares - L N E Bunt and G E Bunt - 35,000 The Bunt Family Trust - 15,000 L N E Bunt and G E Bunt - 35,000 The Bunt Family Trust - 20,000 L N E Bunt and G E Bunt - The Bunt Family Trust - L N E Bunt and G E Bunt Same as current registered holders
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related:
1 16-Mar-20 Purchase of ordinary shares on market n/a $9,250 5,000
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) — include the following details Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
No n/a n/a
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:
==> picture [48 x 31] intentionally omitted <==
18-Mar-20